Security key
31447P100
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)
CUSIP: 31447P100
Q1 2019 13F Holders as of 31 Mar 2019
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 9,638,104
- Total 13F value
- $46,743,906
- Share change
- -99,891
- SEC-reported price per share
- $4.85
- Number of holders
- 44
- Value change
- -$525,691
- Number of buys
- 18
- Number of sells
- 12
- Shares outstanding
- 34,474,972
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2019
Institutions
44
Top holders
10
FENC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
FENNEC PHARMACEUTICALS INC. SEC filings
FENNEC PHARMACEUTICALS INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31447P100
Recent filing periods:
Ownership snapshot
Top reported holders of FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Southpoint Capital Adviso...
Disclosed value leader
Southpoint Capital Adviso...
Comparable rows
15/15
Latest evidence
31 Dec 2018
13F
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
Southpoint Capital Advisors LP leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Southpoint Capital Advisors LP's linked filing trail.
Comparable ownership
Top 5
Southpoint Capital Advisors LP
12%
Avoro Capital Advisors LLC
3.2%
683 Capital Management, LLC
2.8%
Opaleye Management Inc.
2.6%
EVENTIDE ASSET MANAGEMENT, LLC
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Southpoint Capital Advisors LP |
13F
Company
|
12%
|
$25,502,000
3,997,214 shares
|
— | 31 Dec 2018 |
| Avoro Capital Advisors LLC |
13F
Company
|
3.2%
|
$7,056,000
1,105,999 shares
|
— | 31 Dec 2018 |
| 683 Capital Management, LLC |
13F
Company
|
2.8%
|
$6,197,000
971,351 shares
|
— | 31 Dec 2018 |
| Opaleye Management Inc. |
13F
Company
|
2.6%
|
$5,742,000
900,000 shares
|
— | 31 Dec 2018 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
2.1%
|
$4,594,000
720,000 shares
|
— | 31 Dec 2018 |
| BlackRock Finance, Inc. |
13F
Company
|
1.6%
|
$3,588,000
562,216 shares
|
— | 31 Dec 2018 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
44
Shares
9,638,104
Rows available
44
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2019 vs Q4 2025 Across Filers
Q4 2025 holders
96
Q1 2019 holders
44
Holder diff
-52
| Investor | Q4 2025 Shares | Q1 2019 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend